Johnson and Johnson buys Pfizer unit

June 26, 2006 at 9:19 AM

NEW BRUNSWICK, N.J., June 26 (UPI) -- Johnson & Johnson, which is based in New Jersey, is paying $16.6 billion in cash for the consumer healthcare business of Pfizer Inc.

The assets being acquired are personal care and over-the-counter products, such as Listerine, that had 2005 sales of $3.9 billion, Johnson and Johnson said Monday.

Pfizer said the deal, set to close by year-end, would result in about $13.5 billion in after-tax proceeds. Pfizer also said it expects that in the next 18 months it will buy as much as $17 billion of its common stock.

Related UPI Stories
Latest Headlines
Trending Stories
Ted Cruz campaign pulls ad featuring softcore porn actress
Report: Clinton Foundation subpoenaed by State Dept. watchdog over charity projects
Ruby Rose, Gigi Hadid react to Kanye West's lyric about Taylor Swift
Kristen Wiig impersonates Peyton Manning on 'The Tonight Show'
NYC police officer found guilty of manslaughter in Brooklyn stairway shooting